العربية · The Impact of AI
Verified reporting, original sources and clear analysis of what changes for people.
2026-09-28 · UK edition · 111 reports across the archive
Translation is temporarily unavailable. This page currently shows the UK English original. Open the UK edition.
A published research system uses pathologists' viewing behaviour to guide slide analysis and reports stronger performance on a lymph-node metastasis task. It has not shown improved patient outcomes.
The World Health Organization issued recommendations for researchers, ethics committees, regulators, funders and policymakers covering AI data science, research conducted with AI tools and studies of AI health systems.
A Nature Medicine analysis examines running medical AI agents inside a health organisation's own infrastructure to improve data control, reliability and integration with clinical systems.
Researchers extended the AMIE system to collect histories and reason across repeated interactions, exploring how an AI agent might support longer disease-management pathways rather than a single clinical question.
A Nature study using seven real-world clinical datasets found that membership-inference attack success can vary between patients, challenging the idea that one average privacy score protects everyone equally.
A Nature review assesses the safety and security of large language models themselves and the risks created when they are connected to hospital data, software and human workflows.
The US Food and Drug Administration opened a public discussion on risk assessment, premarket evidence and postmarket monitoring for generative-AI-enabled medical devices.
Updated good-machine-learning-practice principles from the FDA, Health Canada and the MHRA emphasise representative data, human-AI team performance and monitoring across the full device lifecycle.
NIH-funded researchers developed a system that interprets three-dimensional CT images to identify abdominal conditions and potential early markers of chronic disease.
APHRC and J-PAL are helping deliver the $60 million EVAH initiative to fund rigorous, locally led evaluations of AI in healthcare across Africa, South Asia and Southeast Asia.
A commission hosted by the medicines regulator proposes staged approvals and lifetime monitoring for AI medical devices. It is a direction of travel, not yet a new legal regime.